Maybe in the past for your research, but hasn't everything changed now that new law took effect few weeks' ago where anything of $10 value free to physician from drug rep reported publicly of both physician and rep?
Seems like this PROBLEM is what shareholders should be pressing AMRN management to address.
All the good results in trials... past and future... MAY NOT GET ANYTHING ACCOMPLISHED if access to the doctors who would make the decisions to prescribe V IS DENIED... and those docs CONTINUE to refuse to see AMRN (who?????) sales reps!
WAITING for the trial results and word of mouth of current V users to OPEN THAT BIG DOOR may take MORE YEARS than AMRN can survive!!!!
Teebone: AMEN ! If you are familiar with basic Physics, The Law of Kinetic Energy applies directly to Marketing. If you put a number of molecules in a fixed space container, the number of interactions is directly related to the number of molecules. If you triple the number of molecules in the fixed space, the number of interactions triples. Same principle applies to the number of Reps trying to sell Vascepa.
Market Data 
Markets 
